(561) 802-3060 info@mri-news.com

This study is now closed to enrollment. To view currently enrolling studies please go to our currently enrolling studies page. For information on additional studies that will open in the future, please visit our upcoming studies page.

 

NASH . . . Is Your Liver At Risk?

Non-alcoholic steatohepatitis (“NASH”) occurs when inflammation and/or liver damage is present in addition to an excess amount of fat.

This form of liver disease is serious and can lead to scarring of the liver.


Join the search for an effective therapy for nonalcoholic fatty liver disease.

Clinical Study Now Enrolling in West Palm Beach

 

Clinical Research Study Flyer for NASH


*We respect your privacy. All information submitted in this form is transmitted over secure servers, and will be kept strictly confidential and will not be shared without your permission, except as required by law. In response to your inquiry, your information will be added to our in-house database and you will be contacted by email and/or phone by a member of the clinical study team to discuss research opportunities available to you.


Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.


1515 North Flagler Drive  •  Suite 440  •  West Palm Beach, FL 33401  •  (561) 802-3060  •  info@mri-news.com

© Metabolic Research Institute, Inc. 2016-2023  All Rights Reserved.

1465938695_social_style_3_facebook    1465938735_social_style_3_googleplus